Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Chimerix Inc (NASDAQ:CMRX)

4.39
Delayed Data
As of Dec 14
 -0.04 / -0.90%
Today’s Change
4.17
Today|||52-Week Range
6.64
-4.57%
Year-to-Date
No recent news for Chimerix Inc.

Today’s Trading

Previous close4.43
Today’s open4.43
Day’s range4.39 - 4.55
Volume420,288
Average volume (3 months)224,053
Market cap$208.8M
Data as of 4:00pm ET, 12/14/2017

Growth & Valuation

Earnings growth (last year)+38.20%
Earnings growth (this year)+0.82%
Earnings growth (next 5 years)--
Revenue growth (last year)-47.02%
P/E ratioNM
Price/Sales37.33
Price/Book0.75

Competitors

 Today’s
change
Today’s
% change
NEOSNeos Therapeutics In...-0.35-3.43%
ALBOAlbireo Pharma Inc+0.32+1.38%
NBRVNabriva Therapeutics...-0.14-2.55%
SBBPStrongbridge Biophar...-0.20-3.15%
Data as of 4:00pm ET, 12/14/2017

Financials

Next reporting dateMarch 9, 2018
EPS forecast (this quarter)-$0.49
Annual revenue (last year)$5.7M
Annual profit (last year)-$76.4M
Net profit margin-1,339.71%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
M. Michelle Berrey
Chief Financial Officer, Secretary &
Senior VP
Timothy W. Trost
Corporate headquarters
Durham, North Carolina

Forecasts